Skip to main content
  • Home
  • Dr Roxana Mehran

Roxana Mehran

Professor of Medicine

Mount Sinai Hospital, New York, NY, US

Biography

Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, FSCAI is Professor of Medicine and Director of Interventional Cardiovascular Research and Clinical Trials at the Zena and Michael A. Weiner Cardiovascular Institute at Mount Sinai School of Medicine.

Dr. Mehran is currently Professor of Medicine, Cardiology and Professor of Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai in New York. She is also Director of Interventional Cardiovascular Research and Clinical Trials at The Zena and Michael A. Weiner Cardiovascular Institute at Mount Sinai Hospital where, over the past five years, she has led the development of a globally-respected data and clinical coordination center to support large, multicenter, multinational clinical trials designed, by her team, to help clinicians improve outcomes and quality of life for patients undergoing interventional cardiovascular procedures. In recent years, her work has had a special emphasis on gaining a deeper understanding of anticoagulation and antiplatelet regimens post angioplasty and transcatheter valve replacement; and collection and interpretation of sex-specific data in cardiovascular clinical trials.

Dr. Mehran serves on editorial board of multiple peer reviewed journals, including Journal of the American College of Cardiology, Circulation, and Circulation Research. She currently serves on the board of trustees of SCAI, as a member of the Program Committee for the American Heart Association Scientific Sessions, as a member of the board of directors for Harboring Hearts, and as Program Chair for Society of Cardiac Angiography and Interventions (SCAI- WIN (Women in Innovations)) Initiative, and is also the Chief Scientific Officer of the Clinical Trials Center at the Cardiovascular Research Foundation (NYC).

Featured Courses

TIO 2021 – Controversies in Current Practice: Live Case and Discussion
  • 1.00 EBAC

Learning objectives

  • Discuss the expanding number of indications in TAVI
  • Select appropriate devices for specific patient groups
  • Recall advances in invasive imaging techniques to aid clinical decision making
  • Summarise the essential principles of mechanical circulatory support
See more
TIO 2021 – Controversies in Current Practice: Keynote Presentation and Controversies
  • 1.00 EBAC

Learning objectives

  • Discuss the expanding number of indications in TAVI
  • Select appropriate devices for specific patient groups
  • Recall advances in invasive imaging techniques to aid clinical decision making
  • Summarise the essential principles of mechanical circulatory support
See more
TIO 2021 – Structural Heart Disease: Expanding Indications in TAVI
  • 1.00 EBAC

Learning objectives

  • Discuss the expanding number of indications in TAVI
  • Select appropriate devices for specific patient groups
  • Recall advances in invasive imaging techniques to aid clinical decision making
  • Summarise the essential principles of mechanical circulatory support
See more
TIO 2021 – Structural Heart Disease: Live Cases and Discussion
  • 1.00 EBAC

Learning objectives

  • Discuss the expanding number of indications in TAVI
  • Select appropriate devices for specific patient groups
  • Recall advances in invasive imaging techniques to aid clinical decision making
  • Summarise the essential principles of mechanical circulatory support
See more
P2Y12 Receptor Inhibitors in Non-ST-Segment Elevation Acute Coronary Syndrome Patients
  • 1.00 EBAC

Learning objectives

  • Recall the supportive evidence underpinning recommended antiplatelet approaches in individuals with unknown coronary anatomy, including choice of therapy, duration, timing and loading doses
  • Compare the design of different clinical trials that have influenced antiplatelet therapy choice in NSTE-ACS patients who proceed to PCI
  • Apply trial data and clinical guidelines on the use of antiplatelet therapy in patients undergoing revascularisation to a surrogate patient case
See more
TIO 2020 – CHIP Live Cases
  • 1.00 EBAC

Learning objectives

  • Evaluate emerging clinical data related to interventional cardiology practice including for both devices and pharmacology
  • Recognise the latest interventional approaches for SHD and Complex PCI available for the optimal management of CV patients
  • Assess the merits of adopting emerging technologies within their practice
  • Apply the practical guidance to maximise success of their interventional procedures within TAVR, Mitral & Tricuspid Valve Replacement and Complex PCIs
  • Interact with opinion leaders in their profession
See more
TIO 2020 – Focus on Calcified Lesions
  • 1.00 EBAC

Learning objectives

  • Evaluate emerging clinical data related to interventional cardiology practice including for both devices and pharmacology
  • Recognise the latest interventional approaches for SHD and Complex PCI available for the optimal management of CV patients
  • Assess the merits of adopting emerging technologies within their practice
  • Apply the practical guidance to maximise success of their interventional procedures within TAVR, Mitral & Tricuspid Valve Replacement and Complex PCIs
  • Interact with opinion leaders in their profession
See more
TIO 2020 – Lean TAVI and Physiology Guided MVD PCI Live Cases
  • 1.00 EBAC

Learning objectives

  • Evaluate emerging clinical data related to interventional cardiology practice including for both devices and pharmacology
  • Recognise the latest interventional approaches for SHD and Complex PCI available for the optimal management of CV patients
  • Assess the merits of adopting emerging technologies within their practice
  • Apply the practical guidance to maximise success of their interventional procedures within TAVR, Mitral & Tricuspid Valve Replacement and Complex PCIs
  • Interact with opinion leaders in their profession
See more
TIO 2020 – Trials
  • 1.00 EBAC

Learning objectives

  • Evaluate emerging clinical data related to interventional cardiology practice including for both devices and pharmacology
  • Recognise the latest interventional approaches for SHD and Complex PCI available for the optimal management of CV patients
  • Assess the merits of adopting emerging technologies within their practice
  • Apply the practical guidance to maximise success of their interventional procedures within TAVR, Mitral & Tricuspid Valve Replacement and Complex PCIs
  • Interact with opinion leaders in their profession
See more
TIO 2020 – Live TAVI Cases
  • 1.00 EBAC

Learning objectives

  • Evaluate emerging clinical data related to interventional cardiology practice including for both devices and pharmacology
  • Recognise the latest interventional approaches for SHD and Complex PCI available for the optimal management of CV patients
  • Assess the merits of adopting emerging technologies within their practice
  • Apply the practical guidance to maximise success of their interventional procedures within TAVR, Mitral & Tricuspid Valve Replacement and Complex PCIs
  • Interact with opinion leaders in their profession
See more